Jun-Min Liao - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jun-Min Liao

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Bioengineering & Translational Medicine|October 1, 2025

Spatial-hindrance-based pro-Adalimumab prevents anti-idiotypic antibody interference in pharmacokinetic and therapeutic efficacyBo-Cheng Huang, Yu-Tung Chen, Yun-Chi Lu, et al.

Journal of Nanobiotechnology|February 1, 2022

A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodiesYuan-Chin Hsieh, Jun-Min Liao, Kuo-Hsiang Chuang, et al.

International Journal of Biological Macromolecules|February 27, 2026

Selective activation of pro-anti-CTLA-4 antibody maintains therapeutic efficacy and reduces immune-related adverse eventsBo-Cheng Huang, Shih-Ting Hong, Tzu-Yi Liao, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Bioengineering & Translational Medicine|October 1, 2025

Spatial-hindrance-based pro-Adalimumab prevents anti-idiotypic antibody interference in pharmacokinetic and therapeutic efficacyBo-Cheng Huang, Yu-Tung Chen, Yun-Chi Lu, et al.

Journal of Nanobiotechnology|February 1, 2022

A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodiesYuan-Chin Hsieh, Jun-Min Liao, Kuo-Hsiang Chuang, et al.

International Journal of Biological Macromolecules|February 27, 2026

Selective activation of pro-anti-CTLA-4 antibody maintains therapeutic efficacy and reduces immune-related adverse eventsBo-Cheng Huang, Shih-Ting Hong, Tzu-Yi Liao, et al.

Pageof 2